Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.

Autor: Rautenberg C; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Stölzel F; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Röllig C; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Stelljes M; Department of Medicine A, University Hospital Münster, Münster, Germany., Gaidzik V; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Lauseker M; Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany., Kriege O; Department of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Verbeek M; Department of Medicine III, Technical University of Munich, Munich, Germany., Unglaub JM; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Krause SW; Department V for Internal Medicine, University Hospital Erlangen, Erlangen, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Neuerburg C; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany., Vucinic V; Leipzig: Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany., Jehn CF; Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. Georg, Hamburg, Germany., Severmann J; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany., Wass M; Clinic and Policlinic for Internal Medicine IV, University Hospital Halle (Saale), Halle (Saale), Germany., Fransecky L; Departmenf for Internal Medicine II, University Schleswig-Holstein, Kiel, Germany., Chemnitz J; Gemeinschaftsklinikum Mittelrhein GGmbH, Koblenz, Germany., Holtick U; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Schäfer-Eckart K; Department of Internal Medicine V, Oncology and Hematology, Klinikum Nürnberg, Nürnberg, Germany., Schröder J; Clinic for Heaematology and Stem Cell Transplantation HELIOS Clinic Berlin-Buch GmbH, Berlin, Germany., Kraus S; Division of Hematology and Oncology, Department of Internal Medicine II, University of Würzburg, Medical Center, Würzburg, Germany., Krüger W; Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany., Kaiser U; Department of Hematology and Oncology, St. Bernward Krankenhaus, Hildesheim, Germany., Scholl S; Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany., Koch K; Department of Medicine III, Technical University of Munich, Munich, Germany., Henning L; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Alakel N; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Röhnert MA; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Sockel K; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Hanoun M; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany., Platzbecker U; Leipzig: Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany., Holderried TAW; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany., Morgner A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Sauer T; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Götze KS; Department of Medicine III, Technical University of Munich, Munich, Germany., Wagner-Drouet E; Department of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany., Schetelig J; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Bornhäuser M; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany. Thomas.schroeder@uk-essen.de.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany. Thomas.schroeder@uk-essen.de., Middeke JM; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany. Janmoritz.middeke@ukdd.de.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Oct 04; Vol. 11 (10), pp. 164. Date of Electronic Publication: 2021 Oct 04.

Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.

Autor: Hemmati PG; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Pfeifer K; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Vuong LG; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Jehn CF; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Terwey TH; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., le Coutre P; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Dörken B; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Arnold R; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2018 Jan; Vol. 53 (1), pp. 101-103. Date of Electronic Publication: 2017 Oct 09.

Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.

Autor: Jehn CF; Medizinische Klinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Virchow, Universitätsmedizin Charité, Berlin, Germany. Electronic address: Christian.Jehn@charite.de., Hemmati P; Medizinische Klinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Virchow, Universitätsmedizin Charité, Berlin, Germany., Lehenbauer-Dehm S; Medizinische Klinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Virchow, Universitätsmedizin Charité, Berlin, Germany., Kümmel S; Kliniken Essen Mitte, Klinik für Senologie, Essen, Germany., Flath B; HOPA, Hämatologisch-Onkologische Praxis Altona, Germany., Schmid P; Barts Cancer Institute, Centre for Experimental Cancer Medicine, London, United Kingdom.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2016 Dec; Vol. 16 (6), pp. 514-519. Date of Electronic Publication: 2016 Jun 14.

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.

Autor: Hemmati PG; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Terwey TH; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Na IK; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Jehn CF; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., le Coutre P; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Vuong LG; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Dörken B; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Arnold R; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.

Publikováno v: European journal of haematology [Eur J Haematol] 2015 Dec; Vol. 95 (6), pp. 498-506. Date of Electronic Publication: 2015 Mar 24.

A survey of treatment approaches of malignant ascites in Germany and Austria.

Autor: Jehn CF; Department of Hematology, Oncology and Tumor Immunology, University Hospital Charité, Berlin, Germany, Christian.Jehn@charite.de., Küpferling S, Oskay-Özcelik G, Lüftner D

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2015 Jul; Vol. 23 (7), pp. 2073-8. Date of Electronic Publication: 2014 Dec 21.